Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)

Br J Haematol. 2021 Jan;192(1):216-220. doi: 10.1111/bjh.17132. Epub 2020 Oct 3.

Hendrik F P Runge^{1

2}, Stuart Lacy³, Sharon Barrans⁴, Philip A Beer⁵, Daniel Painter³, Alexandra Smith³, Eve Roman³, Cathy Burton⁴, Simon Crouch³, Reuben Tooze^{4

6}, Daniel J Hodson^{1

2}

¹ Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge, UK.
² Department of Haematology, University of Cambridge, Cambridge, UK.
³ Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
⁴ Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, UK.
⁵ Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
⁶ Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

No abstract available

Publication types